Kyruus Health
Robert Paull is Co-Founder of Lux Capital and focuses on ventures in healthcare. Robert graduated from the University of Virginia and has been a member of the Regional Selection Committee for UVA’s Jefferson Scholars Foundation. Robert was also a member of Motorola’s Research Visionary Board and an invited lecturer at the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute, Yale University, Georgetown, and the University of Virginia. He has been published in Journal of Biomedical Materials Research (Applied Biomaterials) and Nature Biotechnology. Robert was Founding CEO and is currently on the Board of Directors at Harvard Medical School spinout Genocea Biosciences (vaccine discovery). In 2009, Robert was nominated as Biotech CEO of the Year at the World Vaccine Congress. In 2010, Robert was selected as one of the “100 of the Most Inspiring People” by PharmaVoice Magazine. Robert is Co-Founder of Lux Research (emerging technology research), Founding CEO of Kala Pharmaceuticals (mucosal drug delivery), and has served as an Advisor to the Bill & Melinda Gates Foundation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Kyruus Health
5 followers
Kyruus delivers leading enterprise provider search and scheduling solutions that help health systems match patients with the right providers across points of access. Powered by a robust provider data management platform, the ProviderMatch suite of applications - for consumers, access centers, & referring providers - enables health systems to enhance the patient experience and better align patient demand with network capacity.